Companies: 10,795·Total market cap: $144.5T
Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc.

MLYSNASDAQHealthcare● Active
$22.84
$-0.85(-3.59%)
Market Cap$1.5B
P/E Ratio
52W High$47.65
52W Low$12.59

Mineralys Therapeutics, Inc.(MLYS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MLYS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.13B$0.17B$0.07B$0.03B$0.02B
G&A Expenses$0.04B$0.02B$0.01B$0.01B$0.00B
Total Operating Expenses$0.17B$0.19B$0.08B$0.03B$0.02B
Operating Income($0.17B)($0.19B)($0.08B)($0.03B)($0.02B)
Operating Margin %(computed)
Interest Income$0.02B$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.15B)($0.18B)($0.07B)($0.03B)($0.02B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.15B)($0.18B)($0.07B)($0.03B)($0.02B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.29$-3.66$-1.99$-5.77$-3.89
Wtd Avg Shares0.07B0.05B0.04B0.01B0.00B
EBITDA($0.17B)($0.19B)($0.08B)($0.03B)($0.02B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Mineralys Therapeutics, Inc.

关于Mineralys Therapeutics, Inc.(MLYS)损益表

Mineralys Therapeutics, Inc.(MLYS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MLYS实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.15B)(净利率—)。

常见问题

MLYS · 4 问

Mineralys Therapeutics, Inc.(MLYS)2025财年营收为$0.00B,同比down—%。

MLYS revenueMLYS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08